<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045224"><TermName>methoxsalen</TermName><TermPronunciation>(meh-THOK-suh-len)</TermPronunciation><TermDefinition><DefinitionText>A drug used together with UV light to treat psoriasis, vitiligo, and skin nodules of cutaneous T-cell lymphoma. It is also being studied in the treatment of graft-versus-host disease. It belongs to the family of drugs called psoralens and furocoumarins.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705175" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;methoxsalen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705174" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;metoxaleno&quot;" language="es" id="_4"/><SpanishTermName>metoxaleno</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento usado junto con luz UV para tratar la psoriasis, el vitiligo y los nódulos de la piel del linfoma de linfocitos T cutáneo. También está en estudio para el tratamiento de la enfermedad de injerto contra huésped. Pertenece al tipo de los psoralenos y furocoumarinas.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2005-03-02</DateLastModified></GlossaryTerm>
